Sort
10,766 grants matching “checkpoint inhibitor”
Mechanisms and therapeutic implications of temozolomide resistance in glioblastoma
$76,052Matthew McCord · Northwestern University At Chicago · F32 · FY2023 · CA
Dual targeting of cGAS-STING and splicing to prime lung cancer immunogenicity
$76,052Patrick C Gedeon · Brigham And Women'S Hospital · F32 · FY2023 · CA
Functional study of C53 protein as a novel regulator of checkpoint kinases
$75,990Honglin Li · Augusta University · R01 · FY2010 · GM
Mitotic Mechanisms in Alzheimer's Disease
$75,800University Of Washington · R01 · FY2005 · AG
Improvement of cellular immunotherapy during dysbiosis- Resubmission
$75,787Ruud P.m. Dings · Univ Of Arkansas For Med Scis · R01 · FY2025 · CA
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$75,660Anil Shanker · Meharry Medical College · U54 · FY2020 · CA
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$75,660Anil Shanker · Meharry Medical College · U54 · FY2016 · CA
Immune Regulation of Disseminated Cancer Cell Dormancy
$75,600Julio A Aguirre-Ghiso · Albert Einstein College Of Medicine · R03 · FY2022 · CA
Impact of LAG3 on CD8+ T cell motility and migration in the context of cancer immunotherapy
$75,520Andrew Stephen Baessler · University Of Pittsburgh At Pittsburgh · F32 · FY2025 · CA
Evaluate the Role and Mechanism of GPR4 in Immunotherapy-Related Colitis
$75,500Li Yang · East Carolina University · R03 · FY2022 · CA
Evaluate the Role and Mechanism of GPR4 in Immunotherapy-Related Colitis
$75,500Li Yang · East Carolina University · R03 · FY2023 · CA
Investigating the hnRNPA18-HIF-1a axis in solid tumors
$75,447France Carrier · University Of Maryland Baltimore · R01 · FY2024 · CA
Mitochondrial dynamics in human pulmonary hypertension: a new therapeutic target
$75,208Willard William Sharp · University Of Chicago · R03 · FY2013 · HL
Validation of new biomarker for human cancers
$75,000University Of Texas Md Anderson Can Ctr · R03 · FY2005 · CA
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer
$74,947Andrew Y Koh · Ut Southwestern Medical Center · R01 · FY2022 · CA
Targeting MCL-1 dependent apoptotic vulnerability of KRAS-LKB1 NSCLC
$74,886Chendi Li · Massachusetts General Hospital · F32 · FY2021 · CA
Program 4: Leukemia
$74,826David Marc Weinstock · Dana-Farber Cancer Inst · P30 · FY2021 · CA
Immunomodulation by dietary protein restriction
$74,791Roberto Pili · Indiana University Indianapolis · R21 · FY2019 · CA
Program 4: Leukemia
$74,713David Marc Weinstock · Dana-Farber Cancer Inst · P30 · FY2020 · CA
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$74,545Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2023 · CA
Mechanisms driving acute and chronic kidney function decline after immune checkpoint inhibitor therapy for cancer
$74,509Meghan E. Sise · Massachusetts General Hospital · R01 · FY2023 · DK
Molecular mechanisms of genome maintenance during DNA replication and repair
$74,466Kamakoti P. Bhat · Stanford University · K00 · FY2018 · CA
Tumor-derived Exosome Induction of Dendritic Cell Tolerization
$74,292Michael Paul Plebanek · Duke University · F32 · FY2023 · CA
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
$74,288Anil Shanker · Meharry Medical College · U54 · FY2017 · CA
Metabolites regulating macrophage function in colorectal cancer
$74,274Subbaya Subramanian · University Of Minnesota · R03 · FY2023 · CA